NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
- 11 May 2006
- journal article
- review article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 28 (5), 639-647
- https://doi.org/10.1016/j.neurobiolaging.2006.03.013
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic miceBrain, 2005
- Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathologyBrain Research Reviews, 2005
- Inflammation and the Degenerative Diseases of AgingAnnals of the New York Academy of Sciences, 2004
- Modulation of Nuclear Factor-κB Activity by Indomethacin Influences Aβ Levels but Not Aβ Precursor Protein Metabolism in a Model of Alzheimer's DiseaseThe American Journal of Pathology, 2004
- A 90-year-old monozygotic female twin pair discordant for Alzheimer’s diseaseNeurobiology of Aging, 2003
- Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based studyNeurobiology of Aging, 2003
- Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's diseaseJournal of Neuroimmunology, 2003
- Non‐steroidal anti‐inflammatory drug toxicity in the upper gastrointestinal tractJournal of Gastroenterology and Hepatology, 2000
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996